The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
BMY · Healthcare · Shallow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | BMY | PTCT | PGNY | RIGL |
|---|---|---|---|---|
| Moat Score (0–100) | 60 (highest) | 60 (highest) | 60 (highest) | 60 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 57 | 75 (highest) | 69 | 75 (highest) |
| Pricing power | 98 | 100 (highest) | 30 | 99 |
| Returns on capital | — | 0 | 58 (highest) | 8 |
| Balance-sheet safety | 33 | 100 (highest) | 100 (highest) | 92 |
| Capital discipline | 50 (highest) | 24 | 42 | 24 |
| Price vs. high estimate | 27% below high estimate (largest discount to high estimate) | No price data | 300% above high estimate | No price data |
| Market cap | $126.4B | $6.3B | $2.6B | $673M |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |